CNTB
Price
$2.22
Change
-$0.13 (-5.53%)
Updated
Jul 25 closing price
Capitalization
123.35M
ENTA
Price
$7.40
Change
+$0.06 (+0.82%)
Updated
Jul 25 closing price
Capitalization
158.19M
15 days until earnings call
Interact to see
Advertisement

CNTB vs ENTA

Header iconCNTB vs ENTA Comparison
Open Charts CNTB vs ENTABanner chart's image
Connect Biopharma Holdings
Price$2.22
Change-$0.13 (-5.53%)
Volume$122.67K
Capitalization123.35M
Enanta Pharmaceuticals
Price$7.40
Change+$0.06 (+0.82%)
Volume$65.77K
Capitalization158.19M
CNTB vs ENTA Comparison Chart in %
Loading...
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTB vs. ENTA commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Hold and ENTA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CNTB: $2.22 vs. ENTA: $7.40)
Brand notoriety: CNTB and ENTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 76% vs. ENTA: 39%
Market capitalization -- CNTB: $123.35M vs. ENTA: $158.19M
CNTB [@Biotechnology] is valued at $123.35M. ENTA’s [@Biotechnology] market capitalization is $158.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 1 FA rating(s) are green whileENTA’s FA Score has 1 green FA rating(s).

  • CNTB’s FA Score: 1 green, 4 red.
  • ENTA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNTB and ENTA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 3 TA indicator(s) are bullish while ENTA’s TA Score has 4 bullish TA indicator(s).

  • CNTB’s TA Score: 3 bullish, 4 bearish.
  • ENTA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CNTB and ENTA are a bad buy in the short-term.

Price Growth

CNTB (@Biotechnology) experienced а +29.07% price change this week, while ENTA (@Biotechnology) price change was -1.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

CNTB is expected to report earnings on May 15, 2025.

ENTA is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTA($158M) has a higher market cap than CNTB($123M). CNTB YTD gains are higher at: 60.870 vs. ENTA (28.696). CNTB has higher annual earnings (EBITDA): -20.6M vs. ENTA (-87.12M). ENTA has more cash in the bank: 193M vs. CNTB (84M). CNTB has less debt than ENTA: CNTB (940K) vs ENTA (58.7M). ENTA has higher revenues than CNTB: ENTA (64.5M) vs CNTB (26M).
CNTBENTACNTB / ENTA
Capitalization123M158M78%
EBITDA-20.6M-87.12M24%
Gain YTD60.87028.696212%
P/E RatioN/AN/A-
Revenue26M64.5M40%
Total Cash84M193M44%
Total Debt940K58.7M2%
FUNDAMENTALS RATINGS
ENTA: Fundamental Ratings
ENTA
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTBENTA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 9 days ago
71%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CNTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PDIV0.240.05
+27.20%
Premier Development & Investment, Inc.
CDBMF0.56N/A
N/A
Cordoba Minerals Corp.
SMNUF0.02N/A
N/A
Pt Sarana Menara Nusantara, Tbk
TSGTF6.25N/A
N/A
Tsingtao Brewery Co., Ltd.
KRSOF0.49N/A
N/A
KARSAN OTOMOTIV SANAYII VE TICARET AS

CNTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTB has been loosely correlated with AMRN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTB jumps, then AMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTB
1D Price
Change %
CNTB100%
-5.53%
AMRN - CNTB
55%
Loosely correlated
-0.74%
KZR - CNTB
47%
Loosely correlated
-3.58%
ENTA - CNTB
30%
Poorly correlated
+0.82%
INKT - CNTB
28%
Poorly correlated
-2.32%
BTAI - CNTB
26%
Poorly correlated
N/A
More

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ALEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
+0.82%
ALEC - ENTA
42%
Loosely correlated
-1.68%
SCPH - ENTA
40%
Loosely correlated
-4.11%
BEAM - ENTA
40%
Loosely correlated
+3.68%
PRME - ENTA
38%
Loosely correlated
-3.22%
KRYS - ENTA
37%
Loosely correlated
-1.59%
More